BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20014428)

  • 21. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.
    Leonis G; Steinbrecher T; Papadopoulos MG
    J Chem Inf Model; 2013 Aug; 53(8):2141-53. PubMed ID: 23834142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes.
    Capel E; Auclair M; Caron-Debarle M; Capeau J
    Antivir Ther; 2012; 17(3):549-56. PubMed ID: 22293506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats.
    Kostrubsky VE; Strom SC; Hanson J; Urda E; Rose K; Burliegh J; Zocharski P; Cai H; Sinclair JF; Sahi J
    Toxicol Sci; 2003 Nov; 76(1):220-8. PubMed ID: 12944587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport-Metabolism Interplay of Atazanavir in Rat Hepatocytes.
    Nicolaï J; De Bruyn T; Thevelin L; Augustijns P; Annaert P
    Drug Metab Dispos; 2016 Mar; 44(3):389-97. PubMed ID: 26712820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.
    Kouzuki H; Suzuki H; Ito K; Ohashi R; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1043-50. PubMed ID: 9694967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
    Vernochet C; Azoulay S; Duval D; Guedj R; Ailhaud G; Dani C
    AIDS; 2003 Oct; 17(15):2177-80. PubMed ID: 14523274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.
    Kotani N; Maeda K; Watanabe T; Hiramatsu M; Gong LK; Bi YA; Takezawa T; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2011 Sep; 39(9):1503-10. PubMed ID: 21673128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
    Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
    Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice.
    Holmstock N; Annaert P; Augustijns P
    Drug Metab Dispos; 2012 Aug; 40(8):1473-7. PubMed ID: 22550269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-adenosylmethionine and cAMP confer differential cytoprotection against bile acid-induced apoptosis in canine renal tubular cells and primary rat hepatocytes.
    Webster CR; Boria P; Usechak P; Anwer MS
    Vet Ther; 2002; 3(4):474-84. PubMed ID: 12584685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
    Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics.
    Wang L; Prasad B; Salphati L; Chu X; Gupta A; Hop CE; Evers R; Unadkat JD
    Drug Metab Dispos; 2015 Mar; 43(3):367-74. PubMed ID: 25534768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of baseline viral susceptibility on response to darunavir/ritonavir versus control protease inhibitors in treatment-experienced HIV type 1-infected patients: POWER 1 and 2.
    Pozniak A; Opravil M; Beatty G; Hill A; de Béthune MP; Lefebvre E
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1275-80. PubMed ID: 18844462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
    Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
    J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.
    Kostrubsky SE; Strom SC; Kalgutkar AS; Kulkarni S; Atherton J; Mireles R; Feng B; Kubik R; Hanson J; Urda E; Mutlib AE
    Toxicol Sci; 2006 Apr; 90(2):451-9. PubMed ID: 16410371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats.
    Fukuda H; Ohashi R; Ohashi N; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2010 Sep; 38(9):1505-13. PubMed ID: 20538722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
    Kimoto E; Chupka J; Xiao Y; Bi YA; Duignan DB
    Drug Metab Dispos; 2011 Jan; 39(1):47-53. PubMed ID: 20926619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat.
    De Bruyn T; Augustijns PF; Annaert PP
    J Pharm Sci; 2016 Feb; 105(2):846-853. PubMed ID: 26202434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
    von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI
    J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.